Digitalized temperature monitoring in your clinical supply has various advantages, such as a central view of the status of each single investigational medicinal product (IMP), easy data collection and early response to deviations. This leads to higher quality, cost savings and higher patient safety.
Once implemented, the above benefits are quite apparent, but getting there can be complex with many stakeholders involved. In this webinar, the speakers will discuss an actual case study on the implementation of digitalized temperature monitoring.
Register for this webinar to learn about the following: the business drivers for implementation, how the various systems work together and how the processes are aligned over the various stakeholders.
Silke Leiser, Director Clinical Trial Supply, EMD Serono
Silke works as Director in Clinical Trial Supply supporting the healthcare business of Merck KGaA, Darmstadt, Germany which operates in the U.S. and Canada as EMD Serono. Silke is biologist by profession and studied at the University of Mainz and Würzburg. She joined Merck CTS in 2005 and gained her experience in the global clinical trial business. Silke is currently focusing on innovations & technologies for clinical trial supplies. This includes the fields of Interactive response technologies, material demand planning, optimizing supply activities, as well as patient centric approaches on e.g. packaging design, adherence monitoring and digitalization of CTS processes like IMP temp. tracking.Message Presenter
Stefan Dürr, Senior Director, Client Delivery, Head of Drug Supply Center of Excellence, Cenduit
Stefan has been working in the IRT for 15+ years and has been with Cenduit since its inception in 2007. He worked in various project management roles including leading the global project management team at Cenduit. Stefan is currently responsible for client delivery of key customer accounts and heads the Cenduit drug supply center of excellence. He is very passionate about finding innovative solutions for clinical supply challenges.
Stefan holds a Master of Science in Molecular Biology and an International Executive MBA from the University of St. Gallen.Message Presenter
Harald van Weeren, Segment Manager, Clinical Trial Team, Lead Segment Management, Berlinger & Co. AG
Harald van Weeren is Segment Manager Clinical Trials and Team Lead Segment Management at Berlinger & Co. AG. He has over 15 years of experience in Product Management and Market Segment Management in various high-tech industries. Harald holds a PhD in Physics from the University of Twente, Netherlands.Message Presenter
Who Should Attend?
- Clinical trial managers who are seeking to improve the efficiency of their clinical trials
- Quality managers who are seeking ways to further safeguard quality standards
- Medical monitors who are seeking to further safeguard patient safety
- IRT suppliers who are seeking to find new USPs in their product portfolio and want to increase customer satisfaction
- Logistics providers who are seeking to increase customer satisfaction
What You Will Learn
In this case study the panelists will discuss:
- What are the drivers and business goals of digitalized temperature monitoring?
- How the different systems, such as IRT and temperature monitoring, are working together.
- How the processes over the various stakeholders have been aligned.
Berlinger & Co. AG
The Swiss company Berlinger & Co. AG develops, produces, and distributes innovative condition monitoring solutions for pharmaceutical and medical technology products with the aim of further increasing efficiency and improving patient safety. Berlinger has been a family business since it was founded in 1865, which allows us to think far beyond quarterly results.
Berlinger is fully committed to long-term customer success, as they think in generations. Innovation and quality are key for Berlinger to deliver customers success. Berlinger invests a considerable amount in R&D every year to stay innovative as they did the last 155 years, are truly international, and proudly partner with leading pharmaceutical companies and major healthcare organizations in over 175 countries.